Current Treatment Options in Oncology
Springer Science+Business Media
About the journal
Current Treatment Options in Oncology is a journal published by Springer Science+Business Media in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 1527-2729 · 1534-6277
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 4,390 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/11864
Index listings
- MEDLINE · 2000-01-01
- PUBMED · 2017-08-10
- Indexing
- MEDLINE · PUBMED
- APC
- 4,390 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 59 days received→accepted — computed from PubMed (n=61)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1721
Last recorded publication year
2026
h-index
89
i10-index
1145
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 24%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- OncologyCurr Treat Options Oncol
- Source type
- journal
- NLM unique ID (PubMed)
- 100900946
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
Show all subjects (50)
- Cancer Immunotherapy and Biomarkers
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- CAR-T cell therapy research
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Brain Metastases and Treatment
- Brain Metastases and Treatment
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Ovarian cancer diagnosis and treatment
- Gastric Cancer Management and Outcomes
- Ovarian cancer diagnosis and treatment
- Gastric Cancer Management and Outcomes
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Endometrial and Cervical Cancer Treatments
- Endometrial and Cervical Cancer Treatments
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Cardiac tumors and thrombi
- Vascular Tumors and Angiosarcomas
- Cardiac tumors and thrombi
- Vascular Tumors and Angiosarcomas
- Immunotherapy and Immune Responses
- Prostate Cancer Treatment and Research
- Immunotherapy and Immune Responses
- Prostate Cancer Treatment and Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ